Altimmune, Inc. (ALT) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts ALT Hot Sheet
Join SI Premium – FREE
Altimmune, Inc. (NASDAQ: ALT) reported Q3 EPS of ($0.21), $0.06 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $5 thousand versus the consensus estimate of $2.14 thousand.
For earnings history and earnings-related data on Altimmune, Inc. (ALT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Doncasters Group guiding IPO pricing at top of range - Bloomberg
- Varonis Said To Weigh Sale After Takeover Interest - Bloomberg
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
